1 Obstetrics and Gynecology Tashkent State Medical University
ReceivedSep 15, 2026
RevisedSep 30, 2026
PublishedOct 05, 2026
Аннотация
Fetal macrosomia, commonly defined as a birth weight of ≥4000 g or above the 90th percentile for gestational age, remains a frequent and clinically significant complication of pregnancy worldwide. Maternal metabolic syndrome (MetS), characterized by central obesity, insulin resistance or hyperglycemia, dyslipidemia, and arterial hypertension, is increasingly recognized as an important risk factor for excessive fetal growth. This review synthesizes current evidence on the pathophysiological mechanisms and clinical associations linking individual components of maternal MetS with fetal macrosomia and examines their combined predictive value. A narrative review of PubMed/MEDLINE and Scopus-indexed literature was conducted, focusing on cohort and case-control studies, systematic reviews, and meta-analyses published over the past two decades. The evidence indicates that maternal hyperglycemia and compensatory fetal hyperinsulinemia constitute the central pathogenic pathway of macrosomia, consistent with the Pedersen hypothesis. Maternal obesity independently and synergistically increases this risk through chronic low-grade inflammation, dysregulation of leptin and adiponectin, and enhanced placental nutrient transport. Elevated maternal triglycerides and altered lipid indices may further contribute to fetal overgrowth through glucose-independent mechanisms. In contrast, the relationship between hypertensive disorders and macrosomia is more heterogeneous and may be influenced by placental insufficiency, which can attenuate fetal growth. The coexistence of multiple metabolic syndrome components is associated with a substantially greater risk of macrosomia than the presence of individual risk factors alone. Overall, maternal metabolic syndrome components contribute to fetal overgrowth through overlapping but distinct mechanisms, with hyperglycemia, insulin resistance, and dyslipidemia demonstrating the most consistent associations. Early identification and integrated metabolic risk stratification during the first and second trimesters may improve the prediction and prevention of macrosomia-related perinatal complications.
Ключевые слова
metabolic syndrome, fetal macrosomia, gestational diabetes mellitus, insulin resistance, maternal obesity, dyslipidemia, large for gestational age.
Использованная литература
1. Bozkurt, L., Göbl, C. S., Hörmayer, A.-T., Luger, A., Pacini, G., & Kautzky-Willer, A. (2016). The impact of preconceptional obesity on trajectories of maternal lipids during gestation. Scientific Reports, 6, 29971. https://doi.org/10.1038/srep29971
2. Desoye, G., & Carter, A. M. (2022). Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity. Nature Reviews Endocrinology, 18(10), 593-607. https://doi.org/10.1038/s41574-022-00717-z
3. Eslamian, L., Akbari, S., Marsoosi, V., & Jamal, A. (2013). Effect of different maternal metabolic characteristics on fetal growth in women with gestational diabetes mellitus. Iranian Journal of Reproductive Medicine, 11(4), 325-334. https://pmc.ncbi.nlm.nih.gov/articles/PMC3941422/
4. Firatligil, F. B., Tuncdemir, S., Sucu, S., Reis, Y. A., Ozkan, S., Dereli, M. L., Sucu, S. T., & Engin-Ustun, Y. (2025). Association of the triglyceride-glucose index and the ratio of triglyceride to high-density lipoprotein cholesterol with fetal macrosomia in nulliparous pregnant women: A prospective case-control study. BMC Pregnancy and Childbirth, 25, 175. https://doi.org/10.1186/s12884-025-07317-5
5. Gaudet, L., Ferraro, Z. M., Wen, S. W., & Walker, M. (2014). Maternal obesity and occurrence of fetal macrosomia: A systematic review and meta-analysis. BioMed Research International, 2014, 640291. https://doi.org/10.1155/2014/640291
6. Hernández-Baraza, L., Brito-Casillas, Y., Valverde-Tercedor, C., Recio, C., Fernández-Pérez, L., Guerra, B., & Wägner, A. M. (2025). Mechanisms of fetal overgrowth in gestational diabetes: The potential role of SOCS2. Nutrients, 17(9), 1519. https://doi.org/10.3390/nu17091519
7. Ibragimova, N., & Tojieva, I. (2020). The prevalence of gestational diabetes in Uzbekistan [Conference abstract]. Gynecological and Reproductive Endocrinology and Metabolism, 1(Suppl. 1), 515. https://gremjournal.com/wp-content/uploads/2020/11/Abstract-Book-GREM.pdf
8. Migda, M., Migda, M. S., Migda, B., Krzyżanowska, P., & Wender-Ożegowska, E. (2016). Components of metabolic syndrome in the first trimester of pregnancy as predictors of adverse perinatal outcome. Ginekologia Polska, 87(9), 644-650. https://doi.org/10.5603/GP.2016.0060
9. Mou, S. S., Gillies, C., Hu, J., Danielli, M., Al Wattar, B. H., Khunti, K., & Tan, B. K. (2023). Association between HbA1c levels and fetal macrosomia and large for gestational age babies in women with gestational diabetes mellitus: A systematic review and meta-analysis of 17,711 women. Journal of Clinical Medicine, 12(11), 3852. https://doi.org/10.3390/jcm12113852
10. Song, X., Chen, L., Zhang, S., Liu, Y., Wei, J., Sun, M., Shu, J., Wang, T., & Qin, J. (2022). High maternal triglyceride levels mediate the association between pre-pregnancy overweight/obesity and macrosomia among singleton term non-diabetic pregnancies: A prospective cohort study in Central China. Nutrients, 14(10), 2075. https://doi.org/10.3390/nu14102075
11. Song, X., Chen, L., Zhang, S., Liu, Y., Wei, J., Wang, T., & Qin, J. (2022). Gestational diabetes mellitus and high triglyceride levels mediate the association between pre-pregnancy overweight/obesity and macrosomia: A prospective cohort study in Central China. Nutrients, 14(16), 3347. https://doi.org/10.3390/nu14163347
12. Sourinejad, H., Shayan, A., Niyati, S., & Moghaddam-Banaem, L. (2019). The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes. Medical Journal of the Islamic Republic of Iran, 33, 147. https://doi.org/10.34171/mjiri.33.147
13. Wan, Y., Chen, Y., Wu, X., Yin, A., Tian, F., Zhang, H., Huang, X., Wu, L., & Niu, J. (2023). Mediation effect of maternal triglyceride and fasting glucose level on the relationship between maternal overweight/obesity and fetal growth: A prospective cohort study. BMC Pregnancy and Childbirth, 23, 449. https://doi.org/10.1186/s12884-023-05716-0
14. Yuan, Y., Zhu, Q., Yao, X., Shi, Z., & Wen, J. (2023). Maternal circulating metabolic biomarkers and their prediction performance for gestational diabetes mellitus related macrosomia. BMC Pregnancy and Childbirth, 23, 113. https://doi.org/10.1186/s12884-023-05440-9
15. Zakirova, N. I., Zakirova, F. I., & Abdullaeva, N. E. (2022). Features of pregnancy management and birth outcomes in women with fetal macrosomia with active and expectant tactics. Journal of Reproductive Health and Uro-Nephrology Research, 3(4), 77-79. https://www.sammu.uz/en/article/2184
Как цитировать
Karimova Bonu (2026). THE INFLUENCE OF METABOLIC SYNDROME COMPONENTS ON THE DEVELOPMENT OF FETAL MACROSOMIA. Science and Innovation, 5(9), 36-42. https://doi.org/10.67620/sai.59d0004